Application of nafamostat mesylate in hyperbilirubinemia patients with hepatic failure treated by artificial liver support system

GUO Yue, DUAN Lianxiang, LIU Wenrui, LIU Ziyang, LU Jianrao, HU Jing

PDF(1598 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1598 KB)
World Clinical Drug ›› 2024, Vol. 45 ›› Issue (4) : 397-402. DOI: 10.13683/j.wph.2024.04.009
Article

Application of nafamostat mesylate in hyperbilirubinemia patients with hepatic failure treated by artificial liver support system

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 45(4): 397-402 https://doi.org/10.13683/j.wph.2024.04.009

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1598 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉